No Data
No Data
Senti Biosciences Releases KOL Segment Featuring Dr. Stephen Strickland on Advances in Acute Myeloid Leukemia Research
Senti Bio Participates in a Virtual Investor KOL Connect Segment
Senti Bio (NASDAQ: SNTI) to Participate in a Live Virtual Investor Closing Bell Segment
Senti Bio Bolsters Scientific Advisory Board With Appointment of James B. Trager, Ph.D.
Press Release: Senti Bio Bolsters Scientific Advisory Board With Appointment of James B. Trager, Ph.D.
Senti Bio To Release SENTI-202 Clinical Data And Novel Logic Gated Gene Circuit Mechanism Of Action In Oral And Poster Presentations At The American Association For Cancer Research Annual Meeting In Chicago April 25-30, 2025